ZLAB: Zai Lab Limited
Performance
ZLAB +22.65%
Watchlist
Select an item
Summary
ZLAB at a glance
ZLAB returned +22.65% over the past year and -21.16% a year over five years. Its worst drop in that year was -34.73%, smaller than 47% of stocks on Redstone, and its Sharpe ratio of 0.58 beats 55% of stocks on Redstone. It pays no dividends.
Current Drawdown
-0.52%
Rolling Volatility
78.11%
Actions
Metrics
Risk Indicators
Alpha20.30%
Beta0.99x
Sharpe0.58
Sortino0.96
Omega1.10
Calmar0.65
Martin1.75
Profile
About ZLAB
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $3.3B
- Listed
- Sep 2017
- Employees
- 1,797
- Headquarters
- Shanghai
- Website
- zailaboratory.com
Comparisons